Silver Book Fact

Fact image

The Impact of Personalized Medicine on Cancer Survival in Years

Munoz J, Kurzrock R. Targeted Therapy in Rare Cancers: Adopting the orphans. Nat Rev Clin Oncol. 2012; 9(11): 631-42. http://www.ncbi.nlm.nih.gov/pubmed/22965154

Reference

Title
Targeted Therapy in Rare Cancers: Adopting the orphans
Publication
Nat Rev Clin Oncol
Publication Date
2012
Authors
Munoz J, Kurzrock R
Volume & Issue
Volume 9, Issue 11
Pages
631-42
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Baseline lung cancer screening would lead to more than 130,000 additional survivors in 2012.  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets late-stage metastatic melanoma. The medicine contains a gene encoding antigen that may be able to…  
  • From 1975 to 1996, new cancer drugs increased life expectancy of cancer patients by about one year, at an estimated cost of $3,000—well below the estimated value of a statistical…  
  • A modest decrease of 1% in cancer mortality has been estimated to be worth $500 billion in social value.  
  • In the U.S., new cancer drugs have increased life expectancy at birth by 10.7%.